Navigation Links
PreMD Reports Fiscal 2007 Results
Date:3/28/2008

dation of subcontract manufacturers

for the skin cholesterol kits and the second-generation color reader,

as well as for general product improvements;

- An increase of $37,000 in stock-based compensation, a non-cash

expense, due to the vesting of options granted in prior years; and

- Minor changes in other development costs during the period.

General and administration expenses amounted to $3,213,000 compared with $3,025,000 in 2006, an increase of $188,000. The variance primarily reflects:

- An expense of nil in 2007 compared to $175,000 in 2006 for payments

to amend the ColorectAlert License Agreement;

- An increase of $25,000 in distribution expenses (nil in 2006) related

to the third-party warehouse expenses for storage of inventory;

- An increase of $178,000 in performance-based compensation expense

resulting from achievement of milestones;

- A loss of $125,000 related to disposal of obsolete fixed assets

related to skin cholesterol clinical trials;

- An increase of $57,000 in professional fees for legal, audit and

consulting fees related to business development (including

negotiation of the AstraZeneca agreement); and

- An increase of $17,000 in stock-based compensation for options and

stock grants for administrative personnel and consultants resulting

in a non-cash expense of $401,000 compared with $384,000 in 2006; and

- Minor changes in other general and administration costs during the

period.

Interest on convertible debentures (issued on August 30, 2005) amounted to $663,000 in 2007 compared to $678,000 in 2006. The debentures bear interest at an annual rate of 7%, payable quarterly in either cash or stock. In 2007, $543,000 of the interest expense was paid in stock, rather than cash, compared with $281,000 in 2006. Imputed interest of $1,002,000 (
'/>"/>

SOURCE PreMD Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. PreMD Provides Update on 510(k) Application for PREVU(x) POC
2. PreMD Inc. Provides Corporate Update
3. PreMD Announces Valuable Data on PREVU(x) LT Life Insurance Product
4. PreMD Announces FDA Decision on POC Skin Cholesterol Test
5. PreMD Initiates FDA Review Process and Provides Corporate Update
6. PreMD Inc. Announces Debenture Financing
7. PreMD Inc. Signs Agreement with Cosmetics Conglomerate
8. PreMD Inc. Completes Debenture Financing
9. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
10. Haemacure Reports Third Quarter 2007 Results
11. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2014)... AngelWeddingDress.com has recently updated its online store, ... dresses. “If you are looking for gorgeous beach wedding ... possible. Here you can enjoy 70% off discounts and ... a big marriage ceremony is the most important dream ... dress is uppermost priority. Ophelia, one of customers, said, ...
(Date:11/23/2014)... 2014 Syngenta lawsuits are now being ... farmers and agribusinesses that have allegedly incurred significant financial ... Viptera and Agrisure Duracade, genetically modified (GMO) corn ... sale in China. According to a report from Bloomberg ... U.S. corn imports. Because China is the third-largest American ...
(Date:11/22/2014)... Greenville, SC (PRWEB) November 23, 2014 ... back to their communities. AlignLife experience rapid growth in ... upon a very unique opportunity. AlignLife of Simpsonville ... area AlignLife offices for their first annual Toy Drive. ... local charity they would support with this year's toy ...
(Date:11/22/2014)... Recently, UWDress.com, a successful wedding dress shop, has ... in order to prepare for the wedding season. All ... off. , UWDress.com is a reliable company that has ... the new items -- formal wedding guest attire. This new ... including superstar and princess. As one of the leading companies ...
(Date:11/22/2014)... (PRWEB) November 23, 2014 Today, Dylan ... its new collection of wedding dresses; the business offers ... other related accessories for ladies worldwide, allowing them to ... manager of the company, this new collection of chic ... launch. Moreover, they are offered at discounted rates now. ...
Breaking Medicine News(10 mins):Health News:Beach Wedding Dresses Added to Outstanding Online Dress Company AngelWeddingDress.com 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 3Health News:Greenville Area AlignLife Offices Join Together for a Local Toy Drive 2Health News:Formal Wedding Guest Attire Added to UWDress.com 2Health News:Dylan Queen Introduces Its New Wedding Dresses 2
... , sport-specific eyewear to prevent devastating injuriesAUSTIN, Texas, April 9 ... a routine basketball game his senior year of high school ... star who played years of hoops without any injuries. But ... teammate, Stephen ended up with a large laceration on his ...
... to prevent devastating injuriesOKLAHOMA CITY , April 9 ... game his senior year of high school turned into a ... years of hoops without any injuries. But when he was ... up with a large laceration on his left eyelid and ...
... IVF innovator introduces alternative to artificial insemination for less ... struggling to conceive a child usually have had but ... high-cost process of in vitro fertilization (IVF) ... intra-uterine insemination (IUI) , also known as ...
... an unapproved drug, one of 14 given recent warning, will ... (HealthDay News) -- Bowing to the pleas of hospice experts, ... intent to remove from the market an unapproved liquid morphine ... deputy director of the FDA,s Center for Drug Evaluation and ...
... Allscripts-Misys Healthcare Solutions, Inc. ("Allscripts") announced today ... of the special dividend of $5.23 per share ... with Misys plc on October 10, 2008.(Logo: ... dividend, Allscripts disclosed that in general the special ...
... Effective Than Traditional Medical Care ALEXANDRIA, Va., April 9 ... of their readers with back pain, according to a ... 14,000 Americans who experience the condition. In the survey, ... treatment by medical specialists and primary care providers, a ...
Cached Medicine News:Health News:Eye Protection is Essential for Texas Athletes 2Health News:Eye Protection is Essential for Texas Athletes 3Health News:Eye Protection is Essential for Oklahoma Athletes 2Health News:Eye Protection is Essential for Oklahoma Athletes 3Health News:Fertility Docs Cut Costs of IVF Conception by 60 Percent 2Health News:FDA Reverses Stance on Removal of Morphine Painkiller 2Health News:Allscripts Announces Final Tax Treatment of Special Cash Dividend From the Transactions With Misys plc Completed in October 2008 2Health News:Consumer Reports Survey Shows High Satisfaction for Physical Therapist Treatment of Back Pain 2Health News:Consumer Reports Survey Shows High Satisfaction for Physical Therapist Treatment of Back Pain 3
(Date:11/21/2014)... Texas , Nov. 21, 2014  World Hemp ... containing low THC, announces they are now offering legal, ... to Charlotte,s Web type strains grown in medical marijuana ... other neurological disorders, such as Parkinson,s, MS, and spinal ... US laws to pass, because imported CBD Oil Is ...
(Date:11/21/2014)... , 21. November 2014 /PRNewswire/ ... hat heute bekannt gegeben, dass die ... EMA) die Kennzeichnung als Orphan-Medizinprodukt an ... des Unternehmens zur Behandlung von Fibrodysplasia ... seltene, stark beeinträchtigende genetische Krankheit, die ...
(Date:11/21/2014)... Nov. 20, 2014  Market research firm Kalorama information says ... The Buy, in the medical device industry.  The firm ... will produce just 3% growth this year, which led ... of product lines and entrance by acquisition into new ... medical devices, The Global Market for Medical Devices, ...
Breaking Medicine Technology:New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3Kalorama: 2014 The "Year of The Buy" in Medical Device Industry 2
... HONG KONG, Feb. 25, 2011 /PRNewswire-Asia-FirstCall/ -- Golden ... - 801.HK; 910801.TW), China,s leading integrated healthcare enterprise, ... acquire the remaining interests in the Group,s Chinese ... HK$90 million in shares.  Upon completion of the ...
... Calif., Feb. 24, 2011 Amgen (Nasdaq: AMGN ... 3 head-to-head trial that compared XGEVA ™ (denosumab) to ... skeletal-related events (SREs) in 1,901 men with prostate cancer and ... met its primary and secondary endpoints and demonstrated XGEVA,s superiority ...
Cached Medicine Technology:Golden Meditech Acquires Remaining Stake in Chinese Herbal Medicine Business 2Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 2Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 3Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 4Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 5Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 6Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 7Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 8Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 9
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: